Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)

    Supporting research for developing and testing various behavioral interventions and treatment strategies for drug abuse, HIV prevention, chronic pain, and enhancing treatment adherence, including the use of technologies.

    Browse similar grants
    Mental Health Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

    Supports pilot and feasibility studies to prepare substance use and HIV intervention and services research trials, including prevention, treatment, and recovery research.

    HHS-NIH11Due Feb 16, 2027$450,000

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

    Research grant to develop and test new psychosocial interventions for mental disorders, with focus on experimental therapeutics to translate basic science into treatments.

    HHS-NIH11Due Feb 17, 2027

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

    This grant supports developing and testing innovative psychosocial interventions for mental disorders to accelerate translating research into therapies.

    HHS-NIH11Due Feb 17, 2027

    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

    This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.

    HHS-NIH11Due Dec 3, 2026· 15d$275,000

    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

    Supports preclinical and clinical research to develop interventions to prevent or treat substance use disorders and overdose, advancing candidates toward regulatory approval or clinical adoption.

    HHS-NIH11Due Feb 22, 2027$15,000,000